Thousands could benefit from leukaemia drug banned for patients given all-clear after NHS U-turn 

NHS England previously limited Ibrutinib so patients who had been in remission for more than three years missed out. The once-daily pill works by inhibiting the growth of cancerous cells....

Read More »

By: Daily Mail Online - Friday, 10 August

Related Posts